Free Trial Information
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Aberdeen, U.K. soloMERs, humanized shark variable new antigen receptors (VNARs) University of Aberdeen Ophthalmic; cancer Deepbridge Capital...
Read More
BioCentury | May 19, 2016
Finance

Found in translation

...in the U.K. and rest of Europe U.K. £200 ($287) October 2011 Deepbridge Innovation Fund Deepbridge Capital...
Read More
BioCentury | Oct 24, 2011
Financial News

Deepbridge Innovation Fund financial update

...Deepbridge Innovation Fund , location undisclosed Business: Finance Date announced: 10/18/11 Deepbridge Capital and asset manager SL...
Read More
BioCentury | Oct 19, 2011
Financial News

New Deepbridge Innovation Fund targeting $250M

Deepbridge Capital and asset manager SL Investment Management launched the Deepbridge Innovation Fund (DBIF) to invest in life sciences, "eco-innovation" and software, with a target of $250 million. The partners said the fund will target...
Read More
Items per page:
1 - 4 of 4
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Aberdeen, U.K. soloMERs, humanized shark variable new antigen receptors (VNARs) University of Aberdeen Ophthalmic; cancer Deepbridge Capital...
Read More
BioCentury | May 19, 2016
Finance

Found in translation

...in the U.K. and rest of Europe U.K. £200 ($287) October 2011 Deepbridge Innovation Fund Deepbridge Capital...
Read More
BioCentury | Oct 24, 2011
Financial News

Deepbridge Innovation Fund financial update

...Deepbridge Innovation Fund , location undisclosed Business: Finance Date announced: 10/18/11 Deepbridge Capital and asset manager SL...
Read More
BioCentury | Oct 19, 2011
Financial News

New Deepbridge Innovation Fund targeting $250M

Deepbridge Capital and asset manager SL Investment Management launched the Deepbridge Innovation Fund (DBIF) to invest in life sciences, "eco-innovation" and software, with a target of $250 million. The partners said the fund will target...
Read More
Items per page:
1 - 4 of 4